Aiforia secures €20M EIB financing for AI cancer diagnostics
Helsinki-based Aiforia, a deep learning AI company for pathology, secured €20 million in venture debt from the European Investment Bank. The financing, supported under the Commission’s InvestEU programme, will accelerate product development and commercial expansion for AI-powered cancer diagnostics. Aiforia states its CE-IVD marked solutions are
(#source_EU-Startups)